![]() Governments worldwide have created provisions for granting access to drugs prior to approval for patients who have exhausted all alternative treatment options and do not match clinical trial entry criteria.
Patients & Prescribers » Pharmaxis. Adverse Events. For reporting of any adverse events please email adverse. Investigator initiated studies. Bristol-Myers Squibb is a global biopharmaceutical. BMS.com Home » Clinical Trials » Investigator-Sponsored Research » Early Patient Access. Elotuzumab (BMS-901608) Named Patient Program, click here. HAEi Global Access Program is now live! Thousands of patients suffering from HAE will have access to medicines for the first time, with the launch of HAEi Global Access Program, a landmark medication access program. DOR BioPharma announced Friday that it entered into a collaboration with Steward Cross, under which Steward Cross will sponsor the administration of a Named Patient Access Program (NPAP) for orBec in Singapore and Malaysia, as. The non-profit organization that can help you find and apply for any available patient assistance program (PAP) is NeedyMeds. Visit us online today at NeedyMeds.org. ![]() ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2016
Categories |